Awm Investment Company Cut Its Lemaitre Vascular (LMAT) Position by $1.80 Million; Market Valuation Rose; Mathes Company Increases Stake in Texas Instruments (TXN)

April 20, 2018 - By Maria Brooks

Texas Instruments Incorporated (NASDAQ:TXN) Logo

Awm Investment Company Inc decreased its stake in Lemaitre Vascular Inc. (LMAT) by 10.32% based on its latest 2017Q4 regulatory filing with the SEC. Awm Investment Company Inc sold 57,974 shares as the company’s stock rose 13.61% while stock markets declined. The institutional investor held 503,794 shares of the health care company at the end of 2017Q4, valued at $16.04 million, down from 561,768 at the end of the previous reported quarter. Awm Investment Company Inc who had been investing in Lemaitre Vascular Inc. for a number of months, seems to be less bullish one the $791.11M market cap company. The stock increased 0.02% or $0.01 during the last trading session, reaching $41.03. About 18,304 shares traded. LeMaitre Vascular, Inc. (NASDAQ:LMAT) has risen 48.54% since April 20, 2017 and is uptrending. It has outperformed by 36.99% the S&P500.

Mathes Company Inc increased its stake in Texas Instruments Inc. (TXN) by 11.48% based on its latest 2017Q4 regulatory filing with the SEC. Mathes Company Inc bought 3,925 shares as the company’s stock declined 1.51% with the market. The institutional investor held 38,115 shares of the semiconductors company at the end of 2017Q4, valued at $3.98M, up from 34,190 at the end of the previous reported quarter. Mathes Company Inc who had been investing in Texas Instruments Inc. for a number of months, seems to be bullish on the $98.20 billion market cap company. The stock decreased 1.38% or $1.4 during the last trading session, reaching $99.89. About 2.13 million shares traded. Texas Instruments Incorporated (NASDAQ:TXN) has risen 27.36% since April 20, 2017 and is uptrending. It has outperformed by 15.81% the S&P500.

Investors sentiment decreased to 1.01 in 2017 Q4. Its down 0.11, from 1.12 in 2017Q3. It turned negative, as 47 investors sold TXN shares while 383 reduced holdings. 123 funds opened positions while 312 raised stakes. 805.57 million shares or 0.35% more from 802.74 million shares in 2017Q3 were reported. Patriot Wealth accumulated 29,234 shares. Norris Perne And French Llp Mi, a Michigan-based fund reported 2,029 shares. Charter Trust invested in 0.48% or 39,470 shares. Dekabank Deutsche Girozentrale accumulated 0.83% or 1.30M shares. Pictet Asset Mgmt Ltd has invested 0.24% in Texas Instruments Incorporated (NASDAQ:TXN). Covenant Multifamily Offices Lc holds 0.01% or 100 shares in its portfolio. Federated Invsts Pa stated it has 0.15% of its portfolio in Texas Instruments Incorporated (NASDAQ:TXN). Loomis Sayles Limited Partnership holds 0.13% or 605,485 shares in its portfolio. Headinvest Lc owns 55,685 shares or 1.79% of their US portfolio. Whittier Of Nevada stated it has 4,953 shares or 0.04% of all its holdings. Greenwood Capital Associate Lc reported 40,237 shares. Laffer Invs invested in 1.13% or 43,234 shares. Beech Hill Advsr holds 0.17% in Texas Instruments Incorporated (NASDAQ:TXN) or 3,350 shares. 12,041 were reported by Eads And Heald Invest Counsel. 137,281 are held by Mason Street Advsr Ltd Liability Corp.

Since October 26, 2017, it had 0 insider buys, and 30 sales for $208.19 million activity. 450,000 shares were sold by TEMPLETON RICHARD K, worth $43.43M on Thursday, October 26. Shares for $25.40 million were sold by CRUTCHER BRIAN T on Thursday, October 26. 28,352 shares were sold by ANDERSKOUV NIELS, worth $3.10 million. Shares for $1.98 million were sold by Whitaker Darla H on Wednesday, January 31. On Monday, October 30 the insider BABB RALPH W JR sold $2.14 million. $9.40 million worth of Texas Instruments Incorporated (NASDAQ:TXN) was sold by Ilan Haviv.

Mathes Company Inc, which manages about $240.09M and $218.58M US Long portfolio, decreased its stake in Gilead Sciences Inc (NASDAQ:GILD) by 4,300 shares to 14,625 shares, valued at $1.05 million in 2017Q4, according to the filing. It also reduced its holding in Salesforce.Com Inc (NYSE:CRM) by 17,340 shares in the quarter, leaving it with 43,565 shares, and cut its stake in General Electric Co (NYSE:GE).

Among 41 analysts covering Texas Instruments (NASDAQ:TXN), 18 have Buy rating, 3 Sell and 20 Hold. Therefore 44% are positive. Texas Instruments had 113 analyst reports since July 24, 2015 according to SRatingsIntel. Susquehanna maintained the stock with “Buy” rating in Wednesday, July 26 report. Bernstein maintained Texas Instruments Incorporated (NASDAQ:TXN) on Tuesday, September 26 with “Buy” rating. The firm has “Sell” rating by Goldman Sachs given on Wednesday, February 3. The rating was maintained by KeyBanc Capital Markets on Tuesday, November 21 with “Hold”. The firm has “Outperform” rating given on Friday, October 2 by RBC Capital Markets. As per Wednesday, February 7, the company rating was upgraded by Credit Suisse. On Wednesday, January 25 the stock rating was maintained by Cowen & Co with “Market Perform”. The stock of Texas Instruments Incorporated (NASDAQ:TXN) has “Neutral” rating given on Wednesday, January 24 by Nomura. BMO Capital Markets maintained Texas Instruments Incorporated (NASDAQ:TXN) on Tuesday, July 18 with “Buy” rating. Stifel Nicolaus maintained it with “Hold” rating and $85.0 target in Friday, September 1 report.

Awm Investment Company Inc, which manages about $1.06B and $515.30M US Long portfolio, upped its stake in Ultra Clean Holdings Inc. (NASDAQ:UCTT) by 38,284 shares to 785,000 shares, valued at $18.13M in 2017Q4, according to the filing. It also increased its holding in American Superconductor Corp. by 547,888 shares in the quarter, for a total of 1.15 million shares, and has risen its stake in Everspin Technology Inc..

Analysts await LeMaitre Vascular, Inc. (NASDAQ:LMAT) to report earnings on April, 25. They expect $0.20 EPS, up 25.00% or $0.04 from last year’s $0.16 per share. LMAT’s profit will be $3.86 million for 51.29 P/E if the $0.20 EPS becomes a reality. After $0.21 actual EPS reported by LeMaitre Vascular, Inc. for the previous quarter, Wall Street now forecasts -4.76% negative EPS growth.

Since February 26, 2018, it had 0 insider buys, and 3 insider sales for $4.81 million activity.

Investors sentiment decreased to 0.91 in Q4 2017. Its down 0.80, from 1.71 in 2017Q3. It fall, as 24 investors sold LMAT shares while 44 reduced holdings. 19 funds opened positions while 43 raised stakes. 13.74 million shares or 5.25% more from 13.06 million shares in 2017Q3 were reported. 119,849 are held by Principal Fin Group Inc Inc. Ls Inv Advsrs Lc reported 4,424 shares. Commercial Bank Of Montreal Can has invested 0% of its portfolio in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Aqr Cap Mgmt Ltd Company invested 0.01% in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Blackrock has 2.27 million shares. Pnc Gru Inc reported 251 shares. Qs Ltd Company accumulated 6,066 shares or 0% of the stock. Invesco Limited holds 127,175 shares or 0% of its portfolio. Tci Wealth Advsr holds 0% or 34 shares. Raymond James Financial Services Advsrs Inc owns 10,109 shares or 0% of their US portfolio. Schwab Charles Invest Management accumulated 66,051 shares. Biondo Advisors Ltd Company has 0.94% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Assetmark has 0% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT). Credit Suisse Ag owns 0% invested in LeMaitre Vascular, Inc. (NASDAQ:LMAT) for 16,535 shares. First Light Asset Mngmt Ltd Liability stated it has 46,119 shares or 0.4% of all its holdings.

Among 12 analysts covering LeMaitre Vascular (NASDAQ:LMAT), 6 have Buy rating, 0 Sell and 6 Hold. Therefore 50% are positive. LeMaitre Vascular had 37 analyst reports since July 29, 2015 according to SRatingsIntel. The rating was downgraded by Sidoti on Thursday, September 22 to “Neutral”. The rating was initiated by Barrington Research on Thursday, September 10 with “Mkt Perform”. The stock has “Outperform” rating by Cowen & Co on Thursday, April 21. On Wednesday, July 29 the stock rating was maintained by Benchmark with “Buy”. The stock has “Buy” rating by Roth Capital on Monday, December 7. Benchmark downgraded LeMaitre Vascular, Inc. (NASDAQ:LMAT) on Friday, October 27 to “Hold” rating. The firm has “Hold” rating given on Friday, October 27 by First Analysis. On Friday, July 28 the stock rating was maintained by Roth Capital with “Buy”. The company was maintained on Thursday, February 25 by Barrington Research. Barrington Research upgraded the shares of LMAT in report on Wednesday, October 28 to “Outperform” rating.

Texas Instruments Incorporated (NASDAQ:TXN) Institutional Positions Chart

Echostar Corporation-Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


>